Cargando…
Implications of the success of EGFR-targeted therapy in advanced non–small cell lung cancer for its application to the adjuvant setting
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7475551/ https://www.ncbi.nlm.nih.gov/pubmed/32944373 http://dx.doi.org/10.21037/jtd-2020-46 |
| _version_ | 1783579530611392512 |
|---|---|
| author | Takeda, Masayuki |
| author_facet | Takeda, Masayuki |
| author_sort | Takeda, Masayuki |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7475551 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | AME Publishing Company |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-74755512020-09-16 Implications of the success of EGFR-targeted therapy in advanced non–small cell lung cancer for its application to the adjuvant setting Takeda, Masayuki J Thorac Dis Editorial Commentary AME Publishing Company 2020-08 /pmc/articles/PMC7475551/ /pubmed/32944373 http://dx.doi.org/10.21037/jtd-2020-46 Text en 2020 Journal of Thoracic Disease. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
| spellingShingle | Editorial Commentary Takeda, Masayuki Implications of the success of EGFR-targeted therapy in advanced non–small cell lung cancer for its application to the adjuvant setting |
| title | Implications of the success of EGFR-targeted therapy in advanced non–small cell lung cancer for its application to the adjuvant setting |
| title_full | Implications of the success of EGFR-targeted therapy in advanced non–small cell lung cancer for its application to the adjuvant setting |
| title_fullStr | Implications of the success of EGFR-targeted therapy in advanced non–small cell lung cancer for its application to the adjuvant setting |
| title_full_unstemmed | Implications of the success of EGFR-targeted therapy in advanced non–small cell lung cancer for its application to the adjuvant setting |
| title_short | Implications of the success of EGFR-targeted therapy in advanced non–small cell lung cancer for its application to the adjuvant setting |
| title_sort | implications of the success of egfr-targeted therapy in advanced non–small cell lung cancer for its application to the adjuvant setting |
| topic | Editorial Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7475551/ https://www.ncbi.nlm.nih.gov/pubmed/32944373 http://dx.doi.org/10.21037/jtd-2020-46 |
| work_keys_str_mv | AT takedamasayuki implicationsofthesuccessofegfrtargetedtherapyinadvancednonsmallcelllungcancerforitsapplicationtotheadjuvantsetting |